EQS-AFR: MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]


Werte in diesem Artikel

EQS Preliminary announcement financial reports: MeVis Medical Solutions AG / Preliminary announcement on the disclosure of financial statements
MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

04.12.2023 / 15:19 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


MeVis Medical Solutions AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: January 29, 2024
Address: https://www.mevis.de/investor-relations/finanzberichte

Report Type: Financial report (half-year/Q2)

Language: German
Date of disclosure: May 27, 2024
Address: https://www.mevis.de/investor-relations/finanzberichte


04.12.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Internet: http://www.mevis.de

 
End of News EQS News Service

Werbung

1788839  04.12.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1788839&application_name=news&site_id=smarthouse

Aktuelle MeVis Medical Solutions Aktie News

Werbung

MeVis Medical Solutions Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MeVis Medical Solutions nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
01.09.10 MeVis Medical Solutions kaufen SES Research/ Warburg Gruppe
19.05.10 MeVis kaufen SES Research/ Warburg Gruppe
09.11.09 MeVis kaufen SES Research GmbH
16.09.09 MeVis kaufen SES Research GmbH
08.09.09 MeVis kaufen Performaxx Research GmbH